Micah Fisher
Experienced in Empyema

Dr. Micah Fisher

Pulmonary Medicine
Emory health
Emory Clinic At 1365 Clifton Road
1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
Offers Telehealth
27 Years of Experience
Experienced in Empyema
Emory health
Emory Clinic At 1365 Clifton Road
1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Micah Fisher is a Pulmonary Medicine provider in Atlanta, Georgia. Dr. Fisher has been practicing medicine for over 27 years and is rated as an Experienced provider by MediFind in the treatment of Empyema. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, and Interstitial Lung Disease.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Wake Forest University, 1999.0
Residency
University of Pennsylvania
Specialties
Pulmonary Medicine
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine, 2007
Fellowships
Johns Hopkins Bayview Medical Center
Hospital Affiliations
Emory University Hospital Midtown
Emory University Hospital
Saint Joseph's Hospital Of Atlanta, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Good Samaritan Society
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Emory Clinic at 1365 Clifton Road
1365 Clifton Road Northeast, BldgA, Atlanta, GA 30322
Call: 404-778-3261

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
Enrollment Status: Terminated
Publish Date: February 22, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

19 Total Publications

BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
Journal: Respiratory medicine
Published: June 18, 2025
View All 19 Publications
Similar Doctors
Advanced in Empyema
Dr. Shashank C. Patel
Pulmonary Medicine | Emergency Medicine
Advanced in Empyema
Dr. Shashank C. Patel
Pulmonary Medicine | Emergency Medicine

Wellstreet Of Georgia PC

2292 Peachtree Rd, 
Atlanta, GA 
 (4.0 miles away)
404-382-9941
Languages Spoken:
English, Haitian Creole, Hindi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Shashank Patel is a Pulmonary Medicine specialist and an Emergency Medicine provider in Atlanta, Georgia. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Empyema. His top areas of expertise are Tracheitis, Empyema, COVID-19, and H1N1 Influenza. Dr. Patel is currently accepting new patients.

Advanced in Empyema
Dr. Daniel C. Robins
Pulmonary Medicine | Intensive Care Medicine
Advanced in Empyema
Dr. Daniel C. Robins
Pulmonary Medicine | Intensive Care Medicine

Pulmonary & Sleep Medicine Associates

132 Old Norton Rd Ste 101, 
Fayetteville, GA 
 (28.8 miles away)
770-996-6699
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Robins is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Fayetteville, Georgia. Dr. Robins is rated as a Distinguished provider by MediFind in the treatment of Empyema. His top areas of expertise are Lung Metastases, Lung Nodules, Emphysema, Chronic Obstructive Pulmonary Disease (COPD), and Advanced Bronchoscopy. Dr. Robins is currently accepting new patients.

Ram Paramesh
Advanced in Empyema
Dr. Ram Paramesh
Pulmonary Medicine | Intensive Care Medicine
Advanced in Empyema
Dr. Ram Paramesh
Pulmonary Medicine | Intensive Care Medicine

Piedmont Physicians Pulmonary And Sleep Medicine Austell

3820 Medical Park Drive, 
Austell, GA 
 (16.6 miles away)
770-948-6041
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sriram I. Paramesh, M.D., earned his medical degree from Albany Medical College in Albany, N.Y. He completed his residency at the University of Pittsburgh. He received his undergraduate degree from Johns Hopkins University. Prior to joining Piedmont Physicians, Dr. Paramesh was in practice with Georgia Lung Associates. Dr. Paramesh has been practicing medicine since 1999. He holds board certifications in critical care medicine, pulmonary disease and internal medicine. Dr. Paramesh specializes in pulmonary rehabilitation and sarcoidosis.In his spare time, Dr. Paramesh enjoys playing tennis, traveling, fine dining and reading.Dr. Paramesh welcomes new patients and accepts most insurance plans. Dr. Paramesh is rated as a Distinguished provider by MediFind in the treatment of Empyema. His top areas of expertise are Lung Metastases, Acute Interstitial Pneumonia, Bronchiectasis, Gastrostomy, and Advanced Bronchoscopy.

VIEW MORE EMPYEMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fisher's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Fisher is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Pulmonary Veno-Occlusive Disease
    Dr. Fisher is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Acute Interstitial Pneumonia
    Dr. Fisher is
    Advanced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Asthma
    Dr. Fisher is
    Advanced
    . Learn about Asthma.
    See more Asthma experts
  • Cholesterol Pneumonia
    Dr. Fisher is
    Advanced
    . Learn about Cholesterol Pneumonia.
    See more Cholesterol Pneumonia experts
  • Idiopathic Pulmonary Fibrosis
    Dr. Fisher is
    Advanced
    . Learn about Idiopathic Pulmonary Fibrosis.
    See more Idiopathic Pulmonary Fibrosis experts
  • Interstitial Lung Disease
    Dr. Fisher is
    Advanced
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
  • Lung Metastases
    Dr. Fisher is
    Advanced
    . Learn about Lung Metastases.
    See more Lung Metastases experts
View All 9 Advanced Conditions
  • Experienced
  • Asthma in Children
    Dr. Fisher is
    Experienced
    . Learn about Asthma in Children.
    See more Asthma in Children experts
  • Atypical Pneumonia
    Dr. Fisher is
    Experienced
    . Learn about Atypical Pneumonia.
    See more Atypical Pneumonia experts
  • Bronchiectasis
    Dr. Fisher is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Bronchiolitis Obliterans
    Dr. Fisher is
    Experienced
    . Learn about Bronchiolitis Obliterans.
    See more Bronchiolitis Obliterans experts
  • Bronchitis
    Dr. Fisher is
    Experienced
    . Learn about Bronchitis.
    See more Bronchitis experts
  • Bullae
    Dr. Fisher is
    Experienced
    . Learn about Bullae.
    See more Bullae experts
View All 30 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.